Financials
- Market Capitalization 1.11 B
- Employee 113
- Founded 2017
- CEO N/A
- Website www.januxrx.com
- Headquarter Delaware, United States
- FIGI BBG00ZHSKH11
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.54
Relación precio/flujo de caja
85.51
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2362 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.66 USD | -4.61% | -6.37% | -38.55% | +20.88% | 1.17 B USD | ||
| 2380 | KURA Kura Oncology, Inc. - Common Stock | 12.73 USD | -3.41% | +7.61% | +37.18% | +56.58% | 1.13 B USD | ||
| 2409 | SVRA Savara, Inc. - Common Stock | 5.32 USD | -3.10% | -5.17% | +0.95% | +62.69% | 1.09 B USD | ||
| 2422 | AVTX Avalo Therapeutics, Inc. - Common Stock | 19.72 USD | -1.65% | -0.20% | +0.20% | +109.34% | 1.06 B USD |